Armstrong Advisory Group’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-46
Closed -$7.5K 771
2023
Q3
$7.5K Hold
46
﹤0.01% 648
2023
Q2
$8.43K Hold
46
﹤0.01% 599
2023
Q1
$6.13K Buy
+46
New +$5.4K ﹤0.01% 623

Other funds holding ACLS

Armstrong Advisory Group's ACLS Position: Q4 2023 in Review

Armstrong Advisory Group sold out of Axcelis (ACLS) in Q4 2023, closing a stake of 46 shares — an estimated $7.5K sold.

Armstrong Advisory Group first reported a position in ACLS in Q1 2023 and held it in 3 quarters. The position peaked at $8.43K in Q2 2023. 421 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.

  • Armstrong Advisory Group reported no remaining Axcelis position as of Q4 2023 after selling out during the quarter.
  • Armstrong Advisory Group sold 46 Axcelis shares in Q4 2023, an estimated $7.5K.
  • Armstrong Advisory Group first reported a position in Axcelis in Q1 2023 and held it in 3 quarters.
  • Armstrong Advisory Group's Axcelis position peaked at $8.43K in Q2 2023.
  • 421 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.

Based on Armstrong Advisory Group's 13F filing for Q4 2023, filed 17 Jan 2024.